Gustavo H Dayan

Summary

Affiliation: Sanofi Pasteur

Publications

  1. pmc Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil
    Gustavo H Dayan
    Sanofi Pasteur, Swiftwater, Pennsylvania Sanofi Pasteur, Sao Paulo, Brazil Nucleo de Doenças Infecciosas Universidade Federal do Espírito Santo UFES, Vitoria, Espirito Santo, Brazil
    Am J Trop Med Hyg 89:1058-65. 2013
  2. pmc Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus
    Gustavo H Dayan
    Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA 18370, USA
    Viruses 5:3048-70. 2013
  3. doi request reprint Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
    Gustavo H Dayan
    Sanofi Pasteur Inc, Route 611, Discovery Drive, Swiftwater, PA 18370 0187, USA Electronic address
    Vaccine 31:5047-54. 2013
  4. doi request reprint Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age
    Gustavo H Dayan
    Sanofi Pasteur, USA, 1 Discovery Drive, Swiftwater, PA 18370, USA
    Vaccine 30:6656-64. 2012
  5. doi request reprint Medical practices for prevention of perinatal infections in Puerto Rico
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Paediatr Perinat Epidemiol 22:31-9. 2008
  6. ncbi request reprint Assessment of delay in age-appropriate vaccination using survival analysis
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Am J Epidemiol 163:561-70. 2006
  7. pmc Risk factors for mumps at a university with a large mumps outbreak
    Angela S Huang
    Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Public Health Rep 124:419-26. 2009
  8. doi request reprint Seroprevalence of antibody to mumps virus in the US population, 1999-2004
    Preeta K Kutty
    Division of Viral Diseases and 2Global Immunization Division, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Infect Dis 202:667-74. 2010
  9. doi request reprint Mumps vaccine performance among university students during a mumps outbreak
    Margaret M Cortese
    National Center for Immunization and Respiratory Diseases, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 46:1172-80. 2008
  10. doi request reprint Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity
    Margaret M Cortese
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA
    J Infect Dis 204:1413-22. 2011

Detail Information

Publications27

  1. pmc Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil
    Gustavo H Dayan
    Sanofi Pasteur, Swiftwater, Pennsylvania Sanofi Pasteur, Sao Paulo, Brazil Nucleo de Doenças Infecciosas Universidade Federal do Espírito Santo UFES, Vitoria, Espirito Santo, Brazil
    Am J Trop Med Hyg 89:1058-65. 2013
    ..CYD-TDV vaccination elicited a neutralizing antibody response against serotypes 1-4 and was well-tolerated in children/adolescents in a dengue-endemic region...
  2. pmc Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus
    Gustavo H Dayan
    Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA 18370, USA
    Viruses 5:3048-70. 2013
    ..The vaccine elicited strong and durable neutralizing antibody and cytotoxic T cell responses. WN epidemiology impedes a classical licensure pathway; therefore, innovative licensure strategies should be explored. ..
  3. doi request reprint Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
    Gustavo H Dayan
    Sanofi Pasteur Inc, Route 611, Discovery Drive, Swiftwater, PA 18370 0187, USA Electronic address
    Vaccine 31:5047-54. 2013
    ..A candidate recombinant, live-attenuated, CYD tetravalent dengue vaccine (CYD-TDV) has recently demonstrated immunogenicity, efficacy and good tolerability. This study was performed to evaluate three CYD-TDV formulations in adults...
  4. doi request reprint Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age
    Gustavo H Dayan
    Sanofi Pasteur, USA, 1 Discovery Drive, Swiftwater, PA 18370, USA
    Vaccine 30:6656-64. 2012
    ..This Phase II, randomized, double-blind, placebo-controlled, multi-center study in the US assessed the immunogenicity, viremia, and safety of the ChimeriVax-WN02 vaccine...
  5. doi request reprint Medical practices for prevention of perinatal infections in Puerto Rico
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Paediatr Perinat Epidemiol 22:31-9. 2008
    ..Screening rates for rubella and hepatitis B were high; however, implementation of recommendations for prevention of rubella and hepatitis B needs to be improved...
  6. ncbi request reprint Assessment of delay in age-appropriate vaccination using survival analysis
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Am J Epidemiol 163:561-70. 2006
    ..90) compared with those whose caregivers had not completed primary school. Survival analysis methods were helpful in measuring vaccine uptake and should be considered in future surveys when assessing delay in age-appropriate vaccination...
  7. pmc Risk factors for mumps at a university with a large mumps outbreak
    Angela S Huang
    Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Public Health Rep 124:419-26. 2009
    ..S. However, a resurgence of mumps occurred in 2006. We investigated the large outbreak at a university and assessed risk factors for disease...
  8. doi request reprint Seroprevalence of antibody to mumps virus in the US population, 1999-2004
    Preeta K Kutty
    Division of Viral Diseases and 2Global Immunization Division, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Infect Dis 202:667-74. 2010
    ..To understand prior mumps seroprevalence and factors associated with the presence of antibody to mumps virus, data from the 1999-2004 National Health and Nutrition Examination Survey (NHANES) were analyzed...
  9. doi request reprint Mumps vaccine performance among university students during a mumps outbreak
    Margaret M Cortese
    National Center for Immunization and Respiratory Diseases, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 46:1172-80. 2008
    ..We assessed vaccine performance and mumps risk factors, including the possibility of waning vaccine protection...
  10. doi request reprint Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity
    Margaret M Cortese
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA
    J Infect Dis 204:1413-22. 2011
    ....
  11. doi request reprint Recent resurgence of mumps in the United States
    Gustavo H Dayan
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 358:1580-9. 2008
    ..S. schoolchildren beginning in 1990 was followed by historically low reports of mumps cases. A 2010 elimination goal was established, but in 2006 the largest mumps outbreak in two decades occurred in the United States...
  12. doi request reprint Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change
    Preeta K Kutty
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
    Clin Infect Dis 50:1619-28. 2010
    ..Updated guidance, released in 2007-2008, changed the mumps isolation period from 9 to 5 days. It is now recommended that mumps patients be isolated and standard and droplet precautions be followed for 5 days after parotitis onset...
  13. ncbi request reprint Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico
    Gustavo H Dayan
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 195:12-20. 2007
    ..Studies assessing inactivated poliovirus vaccine (IPV) immunogenicity in tropical countries, using the WHO Expanded Programme on Immunization (EPI) schedule, have been limited...
  14. ncbi request reprint Seroprevalence of measles antibody in the US population, 1999-2004
    Geraldine M McQuillan
    Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    J Infect Dis 196:1459-64. 2007
    ..Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999-2004...
  15. ncbi request reprint Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States
    Amy A Parker
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 355:447-55. 2006
    ..In 2005, a 17-year-old unvaccinated girl who was incubating measles returned from Romania, creating the largest documented outbreak of measles in the United States since 1996...
  16. ncbi request reprint Measles outbreak in the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
    Int J Epidemiol 35:299-306. 2006
    ..Reported 1-dose measles vaccine coverage among children aged 12-23 months varied widely (52-94%) between 1990 and 2000...
  17. pmc Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage
    Rebecca H Bitsko
    Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 46:1101-3. 2008
    ..Seven of the eight reverse transcription-PCR-positive specimens were collected during the first 3 days of parotitis, suggesting that viral shedding is minimal after the first 3 days of symptoms...
  18. ncbi request reprint Efforts at rubella elimination in the United States: the impact of hemispheric rubella control
    Gustavo H Dayan
    National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S158-63. 2006
    ..Implementation of rubella control strategies in the Americas, particularly in Mexico, appears to have facilitated rubella elimination in the United States...
  19. doi request reprint Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population
    Anand A Date
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 197:1662-8. 2008
    ..High attack rates among vaccinated young adults reported during the 2006 mumps outbreak in the United States heightened concerns regarding mumps vaccine failure...
  20. pmc Assessment of areas at increased risk for poliovirus circulation in Ecuador
    Gustavo H Dayan
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Epidemiol Infect 132:787-95. 2004
    ..From the 14 environmental samples taken, we identified Sabin viruses in six of the samples; no vaccine-derived polioviruses were isolated. Using this methodology, we found no evidence of undetected poliovirus circulation in Ecuador...
  21. doi request reprint Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?
    Gustavo H Dayan
    Clinical Department, Sanofi Pasteur, Swiftwater, Pennsylvania, USA
    Clin Infect Dis 47:1458-67. 2008
    ..Our findings indicate the need for more-effective mumps vaccines and/or for review of current vaccination policies to prevent future outbreaks...
  22. ncbi request reprint Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002
    Gustavo H Dayan
    Epidemiology and Survaillance Division, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Rev Panam Salud Publica 16:158-67. 2004
    ....
  23. ncbi request reprint The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 116:e1-4. 2005
    ..One exposed, susceptible student returned home during his infectious period, necessitating 2 months of containment efforts in Iowa...
  24. ncbi request reprint Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome
    Gustavo H Dayan
    Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 187:S235-40. 2003
    ..These findings highlight the importance of introducing rubella-containing vaccine in conjunction with measles elimination activities...
  25. pmc Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, MS E 61, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 42:5698-704. 2004
    ..In Argentina, seroprevalence in women more than 15 years old was high regardless of the area of residence. Negative or uncertain varicella history was not a good predictor of immunity. VZV genotype was stable in all areas of the country...
  26. ncbi request reprint Cost-effectiveness of three different vaccination strategies against measles in Zambian children
    Gustavo H Dayan
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Vaccine 22:475-84. 2004
    ..Given the parameters established for this analysis, such a program would be cost-saving and the most cost-effective vaccination strategy for Zambia...
  27. ncbi request reprint Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 14:671-6. 2005
    ..We used data from reports to the Vaccine Adverse Event Reporting System (VAERS) to develop a proxy means of surveillance for the lifecycle of selected vaccine lots...